Severe Neutropenia During Therapy for Concurrent Primary Human Immunodeficiency Virus and Cytomegalovirus Infections

Treatment of primary HIV infection with antiretrovirals is based on theoretical rationale, limited clinical trial data, and the opinions of experts. We describe a patient with concurrent primary HIV-1 and cytomegalovirus (CMV) infections who had severe neutropenia while receiving antiretroviral ther...

Full description

Saved in:
Bibliographic Details
Published inClinical infectious diseases Vol. 28; no. 4; pp. 920 - 921
Main Authors Sutinen, Jussi, Ristola, Matti, Suni, Jukka, Nuutinen, Hannu, Lähdevirta, Juhani
Format Journal Article Conference Proceeding
LanguageEnglish
Published Chicago, IL The University of Chicago Press 01.04.1999
University of Chicago Press
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Treatment of primary HIV infection with antiretrovirals is based on theoretical rationale, limited clinical trial data, and the opinions of experts. We describe a patient with concurrent primary HIV-1 and cytomegalovirus (CMV) infections who had severe neutropenia while receiving antiretroviral therapy. Serologies for antibodies to CMV and HIV and testing to determine plasma HIV RNA viral load (Amplicor HIV Monitor Test, Roche Diagnostic Systems, Branchburg, NJ) were done with use of commercial kits. A search was performed on MEDLINE and AIDSLINE through November 1997 for concurrent acute/primary infections with HIV and CMV. Additional cases were identified by manual searches.
Bibliography:istex:63953A3319AB019F31651403BB19DFBEFDBAE614
Reprints or correspondence: Dr. Matti Ristola, Aurora Hospital, P.O. Box 348, FIN-00029 HYKS, Finland.
ark:/67375/HXZ-XLR7Q3RP-8
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:1058-4838
1537-6591
DOI:10.1086/517246